-
2x higher yield per batch results in lower costs by reducing media use and production runs.
-
MiniPRO mirrors the fluid dynamics and performance of PBS's GMP-scale bioreactors—the PBS-3, PBS-15, and PBS-80
-
24 single-use vessels can be automated in parallel for highthroughput DOEs, media screening, and scale-up optimization
PBS MiniPRO brings full automation and control to early-stage cell therapy process development, incorporating real-time oxygen and pH monitoring, perfusion media exchange, and closed-system operation. Built on PBS’s proven Vertical-Wheel® technology, PBS MiniPRO mirrors the fluid dynamics and performance of PBS’s GMP-scale bioreactors ensuring seamless process transfer and predicable outcomes.
PBS MiniPRO Delivers More:
- Higher yield, lower cost: up to 2× more viable cells per batch
- Full automation at Mini scale: integrated gassing, real-time pH, perfusion and oxygen control
- Closed-system operation: closed sampling, supplementation, and perfusion medium exchange preserving sterility while providing precise input control.
- Seamless path to scale: results at bench scale translate directly to scale-up to 3L, 15L or 80L
- Purpose-built for cell therapy: proven to maintain aggregate homogeneity, phenotype & potency
- Multi-Plex power: run up to 24 vessels at once for rapid optimization and reduced time to market
- ✓ Closed, GMP-compatible
workflows
- ✓ Process development and tech
transfer
- ✓ Parallel culture optimization (up
to 24 vessels
- ✓ Rapid, reproducible small-scale
development